These free D.Pharm (Diploma in Pharmacy) notes on rheumatoid arthritis and osteoarthritis are part of Pharmacotherapeutics, Part II (2nd year). Below is a short summary of what the notes cover. For the full explanation, read the complete PDF notes embedded at the end of the page. You can browse every topic in the Pharmacotherapeutics category.
Table of Contents
Overview of rheumatoid arthritis and osteoarthritis
These notes cover musculoskeletal disorders, focusing on rheumatoid arthritis and osteoarthritis. For each condition they explain the types, causes, pathogenesis, clinical features, non-pharmacological care and drug treatment with NSAIDs, steroids, DMARDs and biologic agents.
Introduction
The conditions that affect the muscles, bones, joints and connective tissue are called musculoskeletal disorders (MSDs). They may be caused by an injury or an illness, or a person may have them from birth.
Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory disorder of the musculoskeletal system. It affects many joints, and also the connective tissues, muscles, tendons and fibrous tissues.
Topics covered: Types of Rheumatoid Arthritis; Etiology of Rheumatoid Arthritis; Pathogenesis of Rheumatoid Arthritis; Clinical Manifestations of Rheumatoid Arthritis; Pharmacological Management of Rheumatoid Arthritis.
Osteoarthritis
Osteoarthritis (OA) is a progressive, degenerative disease of the synovial joints. There is breakdown of cartilage and bone, and the joint cannot repair the damage caused by stress.
Topics covered: Types of Osteoarthritis; Etiology of Osteoarthritis; Pathogenesis of Osteoarthritis.
Key points on rheumatoid arthritis and osteoarthritis
- Rheumatoid arthritis is a chronic, progressive, inflammatory disorder affecting multiple joints, connective tissue, muscles, tendons and fibrous tissues.
- Seropositive rheumatoid arthritis shows antibodies such as anti-CCP or rheumatoid factor in the blood, while seronegative rheumatoid arthritis lacks these antibodies.
- Conventional DMARDs used in rheumatoid arthritis include methotrexate, leflunomide, hydroxychloroquine and sulfasalazine, and early DMARD therapy reduces symptoms.
- Osteoarthritis is a progressive degenerative joint disease with breakdown of cartilage and bone, also called wear-and-tear arthritis or degenerative joint disease.
- Risk factors for osteoarthritis include age above 50 years, obesity, previous joint injury, family history, female sex and poor posture.
Frequently asked questions on rheumatoid arthritis and osteoarthritis
What is the difference between rheumatoid arthritis and osteoarthritis?
Rheumatoid arthritis is a chronic inflammatory disorder involving the immune system, while osteoarthritis is a degenerative joint disease caused by wear and breakdown of cartilage and bone.
Which drugs are used in rheumatoid arthritis?
Treatment includes NSAIDs like ibuprofen and naproxen, corticosteroids like prednisone, conventional DMARDs such as methotrexate, leflunomide, hydroxychloroquine and sulfasalazine, and biologic agents.
What are the symptoms of osteoarthritis?
Symptoms include joint pain, stiffness, reduced range of motion and loss of flexibility, tenderness, inflammation and a grating sensation in the joint.
Download the Full PDF Notes: Musculoskeletal Disorders
This page gives a brief description of what the PDF covers. For more information, read the full embedded PDF notes below.
This page is part of the Pharmacotherapeutics series for D.Pharm students (Diploma in Pharmacy, not Pharm.D) on DPHARM GURU. Bookmark this page and share it with classmates who are preparing for the same exam.
Related notes: 11. PSYCHIATRIC DISORDERS, 12. OPHTHALMOLOGY.
Next: 10. DERMATOLOGY. Back to the Pharmacotherapeutics category.


